posted on 2014-09-22, 00:00authored byFidele Ntie-Kang, Justina Ngozi Nwodo, Akachukwu Ibezim, Conrad
Veranso Simoben, Berin Karaman, Valery Fuh Ngwa, Wolfgang Sippl, Michael Umale Adikwu, Luc Meva’a Mbaze
Naturally occurring anticancer compounds
represent about half of
the chemotherapeutic drugs which have been put in the market against
cancer until date. Computer-based or in silico virtual
screening methods are often used in lead/hit discovery protocols.
In this study, the “drug-likeness” of ∼400 compounds
from African medicinal plants that have shown in vitro and/or in vivo anticancer, cytotoxic, and antiproliferative
activities has been explored. To verify potential binding to anticancer
drug targets, the interactions between the compounds and 14 selected
targets have been analyzed by in silico modeling.
Docking and binding affinity calculations were carried out, in comparison
with known anticancer agents comprising ∼1 500 published
naturally occurring plant-based compounds from around the world. The
results reveal that African medicinal plants could represent a good
starting point for the discovery of anticancer drugs. The small data
set generated (named AfroCancer) has been made available for research
groups working on virtual screening.